FDA will require device makers to tell patients directly when implants fail
S. 3421 — Medical Device Recall Improvement Act of 2025 · Filed by Richard Durbin (D-IL) · Introduced Dec 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill requires medical device manufacturers to notify patients directly when their implanted or life-sustaining devices are recalled, using a standardized electronic format. The FDA must establish the notification system within 2 years, review manufacturer notifications within 2–3 business days, and maintain a public database of all device recalls. Manufacturers who fail to notify patients or use the required format face penalties under federal law.
Why we flagged it
The bill's core function is to mandate direct patient notification of device recalls and establish transparent, standardized electronic reporting. It is a public-health transparency measure, not a deregulatory or industry-favoring provision.
What the text implies
- Manufacturers may face operational costs to build/integrate electronic notification systems, potentially passed to healthcare systems or patients through device pricing.
- The 2–3 business day FDA review window creates a tight timeline; delays could expose patients to risk or create liability disputes over notification timing.
The full analysis lists 4 implications of this text.
Who stands to gain
healthcare IT vendors (electronic notification system development); medical device manufacturers (compliance consulting, system integration)